CAS: 1080622-86-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
CP466722 REF: IN-DA008TF3CAS: 1080622-86-1 | 98% | 51.00 €~260.00 € | Wed 04 Dec 24 | |
CP-466722 REF: TM-T6261CAS: 1080622-86-1 | 99.14% - 99.85% | 35.00 €~1,049.00 € | Wed 11 Dec 24 | |
CP-466722 REF: TR-C781395CAS: 1080622-86-1 | - - - | 1,592.00 € | Tue 14 Jan 25 | |
2-(6,7-dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine REF: 3D-FD43368CAS: 1080622-86-1 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA008TF3
5mg | 51.00 € | ||
10mg | 62.00 € | ||
25mg | 78.00 € | ||
100mg | 151.00 € | ||
250mg | 260.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
CP-466722
CAS:1080622-86-1
CP-466722, an effective and reversible ATM inhibitor, does not inhibit ATR and PI3K or PIKK …
Formula:
C17H15N7O2
Purity:
99.14% - 99.85%
Color and Shape:
Solid
Molecular weight:
349.35
Ref: TM-T6261
1mg | 35.00 € | ||
2mg | 52.00 € | ||
5mg | 74.00 € | ||
10mg | 114.00 € | ||
25mg | 181.00 € | ||
50mg | 293.00 € | ||
100mg | 475.00 € | ||
500mg | 1,049.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
CP-466722
Controlled ProductCAS:1080622-86-1
Applications CP466722 is a competetive, reversible inhbitor of Ataxia telangiectasia (A-T) mutated (ATM) kinase References …
Formula:
C17H15N7O2
Color and Shape:
Neat
Molecular weight:
349.347
Ref: TR-C781395
10mg | 1,592.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
2-(6,7-dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine
CAS:1080622-86-1
2-(6,7-Dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine is an inhibitor drug that is used in the treatment of cancer. It inhibits …
Formula:
C17H15N7O2
Purity:
Min. 95%
Molecular weight:
349.35 g/mol
Ref: 3D-FD43368
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |